1,525 reports of this reaction
2.2% of all DOXYCLYCLINE HYCLATE reports
#3 most reported adverse reaction
NAUSEA is the #3 most commonly reported adverse reaction for DOXYCLYCLINE HYCLATE, manufactured by Lupin Pharmaceuticals, Inc.. There are 1,525 FDA adverse event reports linking DOXYCLYCLINE HYCLATE to NAUSEA. This represents approximately 2.2% of all 70,851 adverse event reports for this drug.
Patients taking DOXYCLYCLINE HYCLATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for DOXYCLYCLINE HYCLATE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for DOXYCLYCLINE HYCLATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 1,525 FDA reports for DOXYCLYCLINE HYCLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.2% of all adverse event reports for DOXYCLYCLINE HYCLATE, making it one of the most commonly reported side effect.
If you experience nausea while taking DOXYCLYCLINE HYCLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.